Summary of Purpose
The main objective of the PROOF trial is to investigate efficacy and safety of normobaric hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in a randomized controlled clinical phase IIb trial.Read More →
The following dates are available for this trial. Trial information last updated on 18 April 2018.
|1 Jun 2018||27 Mar 2018||1 Mar 2021||1 Jun 2021||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Sven Poli, MD MSc FESO
firstname.lastname@example.org +49 7071 290